GlaxoSmithKline to acquire Canadian vaccine maker for $1.4 billion
Hoping to become a major supplier of flu shots to the United States, GlaxoSmithKline has said that it will pay $1.4 billion to acquire ID Biomedical, a Canadian vaccine maker. The deal, announced